← 홈

ADC · 위암

55개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 55개
ADCSHOTFDACuratedFDABiologicDaiichi SankyoDXd (topo-I inhibitor)Approved

trastuzumab deruxtecan (Enhertu, T-DXd, DS-8201)

HER2+ breast cancer, HER2-low, gastric · HER2

#HER2#ADC#Approved#FDA승인#바이오모아추천+5
효능 ORR 79.7%임상시험 215상태 APPROVED
ADCSHOTFDACuratedFDABiologicRemeGenMMAEApproved

disitamab vedotin (Disitamab Vedotin, RC48)

HER2+ urothelial, gastric, breast · HER2

#HER2#ADC#Approved#FDA승인#바이오모아추천+5
효능 ORR 50%임상시험 146상태 ACTIVE
ADCABiologicAstraZenecaPhase 2

5-FU (Fluorouracil, Fluorouracil (5-FU))

Gastric Cancer · Gastric Cancer

#GastricCancer#ADC#Phase2#인기#항체약물접합체+2
효능 ORR 63.5%임상시험 93상태 RECRUITING
ADCABiologicDaiichi Sankyoderuxtecan (Dato-DXd, Datro…Phase 2

trastuzumab deruxtecan (Enhertu, T-DXd, DS-8201, Trastuzumab Deruxtecan (T-DXd) monotherapy)

Gastric Adenocarcinoma; Gastroesophageal Junction Adenocarcinoma · Gastric Adenocarcinoma

#GastricAdenocarcinoma#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 79.7%임상시험 91상태 RECRUITING
ADCBBiologicSuzhou Transcenta Therapeutics …Govitecan in Untreated, Adv…Phase 2

Albumin-bound paclitaxel (Albumin-bound paclitaxel)

Advanced Cancer; Gastric Cancer · Solid Cancer

#SolidCancer#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 63.5%임상시험 75상태 RECRUITING
ADCBiologicRemeGenvedotin plus PD-1 blockade …Phase 2

disitamab vedotin (Disitamab Vedotin, RC48, Disitamab Vedotin(RC48) Plus Tratuzumab)

HER2-positive Gastric Cancer; HER2-positive Gastroesophageal Junction Adenocarcinoma · HER2

#HER2#ADC#Phase2#인기#항체약물접합체+5
임상시험 66상태 RECRUITING
ADCBiologicMerck Sharp & Dohme LLCvedotin combined with pembr…Phase 2

Immune Checkpoint Inhibitor (Immune Checkpoint Inhibitor)

Unspecified Adult Solid Tumor, Protocol Specific · Gastric Cancer

#GastricCancer#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 59%임상시험 66상태 RECRUITING
ADCBiologicAstellas Pharma Global Developm…Phase 3

TAS-102 (TAS-102)

Metastatic Colorectal Cancer · Gastric Cancer

#GastricCancer#ADC#Phase3#인기#항체약물접합체+3
효능 ORR 20%임상시험 61상태 ACTIVE
ADCBiologicGruppo Oncologico del Nord-OvestPhase 3

l-leucovorin (l-leucovorin)

Metastatic Colorectal Cancer · Gastric Cancer

#GastricCancer#ADC#Phase3#인기#항체약물접합체+3
효능 ORR 36.6%임상시험 60상태 ACTIVE
ADCBiologicGenentech, Inc.Preclinical

Anti-angiogenic drug (Anti-angiogenic drug)

Gastric Cancer; Second-line Treatment · Gastric Cancer

#GastricCancer#ADC#Preclinical#인기#항체약물접합체+3
효능 ORR 96%임상시험 59상태 RECRUITING
ADCBiologicRemeGen Co., Ltd.sPhase 2

disitamab vedotin (Disitamab Vedotin, RC48)

Non-Muscle Invasive Bladder Cancer; HER2 · Gastric Cancer/Gastroesophageal Junction

#GastricCancerGastroesophagealJun#ADC#Phase2#인기#항체약물접합체+5
임상시험 56상태 RECRUITING
ADCBiologicAstraZenecaderuxtecan plus fluoropyrim…Phase 3

FLOT Chemotherapy (FLOT Chemotherapy)

Gastrointestinal Neoplasms; Esophagogastric Junction · Gastroesophageal Adenocarcinoma

#GastroesophagealAdenocarcinoma#ADC#Phase3#인기#항체약물접합체+5
임상시험 50상태 RECRUITING
ADCBiologicstaleAstraZenecaPhase 2

Nanoliposomal Irinotecan (Nanoliposomal Irinotecan)

Biliary Tract Cancer · Gastric Cancer

#GastricCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 5%임상시험 31상태 ACTIVE
ADCBiologicstaleCastilla-La Mancha Health Servi…Phase 2

Perioperative treatment (Perioperative treatment)

Hepatoid Adenocarcinoma of Stomach · Hepatoid Adenocarcinoma of Stomach

#HepatoidAdenocarcinomaofStomach#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 31상태 RECRUITING
ADCBiologicstaleDaiichi SankyoPhase 2

trastuzumab deruxtecan (Enhertu, T-DXd, DS-8201, Trastuzmab deruxtecan)

Gastric Cancer; Gastroesophageal Junction (GEJ) Cancer · Gastric Cancer

#GastricCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 71.7%임상시험 31상태 RECRUITING
ADCBiologicstaleShanghai Miracogen Inc.Phase 3

MRG003 (MRG003)

Squamous Cell Carcinoma of the Head and Neck · Advanced or Metastatic Gastric Cancer

#AdvancedorMetastaticGastricCance#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2
임상시험 30상태 ACTIVE
ADCBiologicstaleMerck Sharp & Dohme LLCPhase 3

Nemtabrutinib (Nemtabrutinib)

Conjunctival Mucosa-Associated Lymphoid Tissue Lymphoma; Gastric Mucosa-Associated Lymphoid Tissue Lymphoma · Chronic Lymphocytic Leukemia

#ChronicLymphocyticLeukemia#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 0.0%임상시험 23상태 RECRUITING
ADCBiologicstaleRemeGen Co., Ltd.Phase 3

disitamab vedotin (Disitamab Vedotin, RC48, RC48-ADC（2.0mg/kg）)

Gastric Cancer · Gastric Cancer

#GastricCancer#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+1
임상시험 19상태 RECRUITING
ADCBiologicstaleBoehringer IngelheimPhase 2

Zongertinib (Zongertinib)

Metastatic Breast Cancer; Metastatic Gastric Adenocarcinoma · Metastatic Breast Cancer

#MetastaticBreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 15상태 RECRUITING
ADCBiologicstaleK-Group, Beta, Inc., a wholly o…Phase 1

Azenosertib (Azenosertib)

Clinical Stage III Gastric Cancer AJCC v8; Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 · Clinical Stage III Gastric Cancer AJCC v

#ClinicalStageIIIGastricCancerAJC#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 12상태 RECRUITING

1 / 3 페이지

← 이전다음 →